SCIENTIFIC ABSTRACT YAKOVLEVA, Z. M. - YAKOVLEVSKIY, O. V.

Document Type: 
Document Number (FOIA) /ESDN (CREST): 
CIA-RDP86-00513R001962010005-7
Release Decision: 
RIF
Original Classification: 
S
Document Page Count: 
100
Document Creation Date: 
November 2, 2016
Document Release Date: 
September 17, 2001
Sequence Number: 
5
Case Number: 
Publication Date: 
December 31, 1967
Content Type: 
SCIENTIFIC ABSTRACT
File: 
AttachmentSize
PDF icon CIA-RDP86-00513R001962010005-7.pdf5.9 MB
Body: 
SO -0/ -151 WJRC&_CODE_F_UR C C NN 029T/65/01 /0 /6156 V AUTHOR: BuIcharb, 0. T._;_.Yakcrvleva,,,ZM.- 7 Ebert/ -ORG:- -,Departmant. q~ Microbiqlogy/~Oatded by-N-0fosa Medicaj.~'rj"stjt t n u e TlTLE: Concerning the protective nonspecific action of lysozyme in infection SOURCE: Antibiotiki, v. 10p no. 21 1965, 151-156 TOPICIAGS: mouse, rabbito vitamin, bacteria, drug effect ABSTRACT: -Mice and rabbits were used in experiments which were carried out to determine the efficacy of lysozyme and its combinations with vitamins It- Bj) B6, and B12) when used for the prophylaxis of infqctiou3 processes indu- ced by Salmonella_typhimiriurivand Bacterium pyocyan. I Crystalline and liquId forms of the vitamins were tested. In the experiments with Salmonella typhimurium the mice were divided into four groups; group one was adminis- -tered lysozyme only in dose3 of one milligram per mouse; the mice of the .second group received a mixture of the vitamins, the third group was administered simultaneously lysozyme and a mixture of the vitamins; the fourth group received a physiolo3ical solution only. On the day following .the administration of the proparationap the animale were ouboutaneously ,infected with LE~90 (4000 microbic colls) of Salinonella typhimurium. In the experiments with Dacterimn pyocyanewm, all of the animals were divided into six groupop each or the groups having received respectively lysozymop Card 1/2 UDC: 615-779.935-092.19: 616-022-7/-9 ACC Kt: AP6014661 lysozyme with vitamin combinations and -matures of vitamins administered at ;'diffcrent periods prior to.their infection with the microorganisms which -were administered in-LDIOO dosesintraperitoneally. The experiments estab- that lysozyme ana-its combinations with vitamins k. B and BL2 are prophylactically effective in relation to infections induced t; Salmonella ityphimurium and Bacterium pyocyaneum; that although lysozyme itself stimu- lates phagocytoais) its stimulating effect on phagocytosie is more intense ,.yhon applied in combination.with,'the'group of B vitamins; the administration .of lysozyme and the vitamins elevated the le-~el of'no-rmal typhoids paratyphoid B,, ,4nins in rabbits. Orig. art. has: 1 figure and and dysentery Flexner C aggl ;4 3 tables.. PPRSI SUB CODE: 06 SUBM DATE2-`~27M464 ORIG REF.- 012 OTH REF: 006 Card 1, o6685-67 r, N-1 ( 1) .7 K 6 0 2 8 9 5 0 SOURCE' CODE: UR/0219/66/062/008/6068VO-O70- AUTHORt Bukha-rin, 0. V,; Y~ikovLeva,.Z. H. ff ORG: Department of Microbiology /Director-Prof. L. Ya. Ebert/, binnk Medicnl Institute (Kafedra mikrobiologii Chelynbinakogo moditsin-; skogo instituta) TITLE: Protective affect of prodigiozan an experimental infections and immunologica reactions of the body SOURCEt Byulleten' eksperimentallnoy biologii i meditainy, ve 62,. no. 8, 1966, 68-70 TOPIC TAGS: bacterial polysaccharide, immunologyo protective effect,. .prodigiozan ABSTRACT: The effect of prodigiozan4)(series 266 developed in Z. V. Yermol'yeva'a laboratory) on_Salmonella typhimurium~qwas studied using 120 white mice weighing 18-20 g. Prior to the experiment, the animals were injected subcutaneously with a 1 pg/kg dose of prodigiozont pro- digiozan with vitamins B1, B6, and B12, or vitamins alone. They were then injected subcutaneously with a lethal (LD100) dose of Salmonelza (4000 microbe,calls). Mean viability was used as the criterion for the effectiveness of the preparation, Humoral factors of immunity were Card l/ 3 um 615.779o925-06t6l6*9-09299 L o8685-67 ACC' N RI ___JCP_6*dY8'�_~76 studied using 32 guinea pigs and 150 white mice. Here, normal anti- bodYtDcontent and the immunolo8ical activity of blood serum in guinea i pigs and mice administered 1 Ijg/g of prodigiozan were determined. After an hour mice were then injected intraperitoneally with an LDSO (50 x 1;6 cells) dose of Bact. pyocyaneum. Paired sera were admin- istored in 0,2 ml doses (1;2 dilution), Some results of these studies are L'.ivsu in Table 1. It was concluded that prodigioxan was able to Table 1. Protective affect of prodigiozan on Sal- monetla infected mice No* Preparation No* of animals Haan viabil- ity (in days) P 1e Placebo 30 4.5.+.0.4 - 2. Prodigiozan 30 6,70,4